Brexit and the Life Sciences sector

Posted on 30 November 2020

One of the sectors particularly affected by Brexit is the life sciences industry. Notwithstanding the additional regulatory demands of COVID-19, the MHRA has produced a series of guidance documents, some still in consultation form, setting out the framework for how medicines and medical devices will be regulated.

Read more here.

How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

COVID-19 Enquiry

I'm a client

I'm looking for advice

Something else